Table 4.

Patients’ benefits related to current antihistamine treatment

	mean ± SD*	Percentage of patients helped rather/a lot**	Weighted subscore m ± SD***
To be healed for all symptoms	3.1 ± 0.9	92.8%	0.21 ± 0.11
To no longer have a runny or blocked nose	3.0 ± 0.9	91.9%	0.19 ± 0.11
To be able to breathe through my nose more freely	3.0 ± 1.0	91.6%	0.19 ± 0.11
To not have sneezing impulses	2.9 ± 1.0	89.9%	0.17 ± 0.10
To not experience eye, nose or palate stinging anymore	2.8 ± 1.0	88.0%	0.16 ± 0.10
To be able to stay outdoors without symptoms	2.9 ± 1.0	90.0%	0.16 ± 0.10
To be able to engage in normal leisure activities	2.8 ± 1.1	85.3%	0.15 ± 0.08
To have a treatment which is easy to use	2.7 ± 1.2	81.2%	0.14 ± 0.10
To experience more enjoyment of life	2.6 ± 1.2	81.8%	0.13 ± 0.08
To not have burning or watery eyes anymore	2.8 ± 1.1	85.0%	0.15 ± 0.09
To have confidence in the therapy	2.6 ± 1.2	80.5%	0.13 ± 0.09
To be able to sleep better	2.5 ± 1.3	76.0%	0.12 ± 0.09
To feel less fatigued or groggy	2.4 ± 1.2	75.6%	0.11 ± 0.07
To be able to concentrate better at work	2.4 ± 1.2	74.1%	0.10 ± 0.07
To be more productive in everyday life	2.4 ± 1.2	75.7%	0.10 ± 0.06
To feel less burdened in your relationship	2.3 ± 1.3	72.1%	0.09 ± 0.07
To have fewer side effects	2.2 ± 1.3	69.3%	0.09 ± 0.07
To have no fear that the disease will become worse	2.2 ± 1.3	69.2%	0.09 ± 0.07
To feel more comfortable in public	2.3 ± 1.3	72.2%	0.09 ± 0.07
To be able to have a normal sex life	2.0 ± 1.4	59.5%	0.08 ± 0.07
To feel less depressed	2.0 ± 1.3	62.0%	0.07 ± 0.06
To feel less irritated	2.1 ± 1.3	63.8%	0.07 ± 0.06
To be less dependent on Doctor and clinic visits	2.0 ± 1.3	63.2%	0.07 ± 0.06
To spend less time on daily treatment	2.0 ± 1.4	60.1%	0.07 ± 0.06
To have fewer out-of-pocket treatment expenses	1.8 ± 1.4	54.9%	0.06 ± 0.06
Global weighted PBI	2.7 ± 0.8
Patients with global PBI ≥1	2956 (96.5%)

Analysis of the Patient Benefits Questionnaires filled-in after antihistamine treatment. Patient’s benefits are ordered by decreasing importance of the corresponding need. Treatment-related benefits are scaled from 0 ‘did not help at all’ to 4 ‘helped a lot’. *Data are described as mean ± SD. **Percentage of patients with the need achieved by treatment from ‘rather helped’ to ‘helped a lot’ among afflicted patients at treatment initiation; ***PBI subscores weighted by the relative amount of the corresponding patient’s need.